Literature DB >> 4719678

Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.

P H Schreibman, D L Arons, C D Saudek, R A Arky.   

Abstract

A 5-yr old male proband and his sister have had hypertriglyceridemia and hepatosplenomegaly since birth. When studied on a metabolic ward, they demonstrated rapid decreases in serum triglycerides on 3 g fat/day diets. Oral glucose tolerance tests were normal. Postheparin lipolytic activity (PHLA) against chylomicrons was virtually absent in both children whereas the mother and a normolipemic sister had levels approximately 50% normal. However, all four had a normal PHLA against commercial triglyceride emulsion (Intralipid). Two unrelated children from different kindreds of typical type 1 hyperlipoproteinemia and two patients with acquired type V hyperlipoproteinemia had deficient PHLA against both substrates. No inhibitors of PHLA could be demonstrated in the proband's plasma, and his own PHLA could not be enhanced by either normal concentrated plasma or pooled d > 1.063 lipoprotein fraction. The proband's postheparin plasma required almost 20 times the normal chylomicron-triglyceride concentration to reach one-half maximal lipase velocity. Both affected siblings showed heavy pre-beta lipoprotein electrophoretic bands plus chylomicrons in their fasting plasmas while ingesting a 33% carbohydrate, 30% fat diet. Incubation of their postheparin plasma with S(f) > 400 chylomicrons in vitro produced a smaller S(f) 20-400 "remnant" with pre-beta electrophoretic mobility that was not seen under the same conditions when normal postheparin plasma was used. Postheparin monoglyceridase and phospholipase activities were either normal or only moderately decreased when determined with appropriate artificial substrates. These data are consistent with either (a) a mutant gene producing a lipoprotein lipase with unusual substrate specificities or (b) an absolute deficiency of normal lipoprotein lipase with a compensatory increase in some other postheparin triglyceridase.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4719678      PMCID: PMC302490          DOI: 10.1172/JCI107392

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  NEW EFFECTS OF SODIUM CHLORIDE AND PROTAMINE ON HUMAN POSTHEPARIN PLASMA 'LIPOPROTEIN' LIPASE ACTIVITY.

Authors:  D V DATTA; H S WIGGINS
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  Heparin-released lipolytic and esterolytic activities of human and rabbit plasmas.

Authors:  B SHORE; V SHORE
Journal:  Am J Physiol       Date:  1961-11

3.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

4.  Correlation between post-heparin lipase and phospholipase activities in human plasma.

Authors:  W C Vogel; E L Bierman
Journal:  Lipids       Date:  1970-04       Impact factor: 1.880

Review 5.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

6.  Triglyceride breakdown in rat liver. The demonstration of three different lipases.

Authors:  W Guder; L Weiss; O Wieland
Journal:  Biochim Biophys Acta       Date:  1969

7.  Hepatic lipase in the rat.

Authors:  J R Carter
Journal:  Biochim Biophys Acta       Date:  1967-02-14

8.  Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).

Authors:  W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

9.  Post-heparin lipolytic activity in diabetic patients with a history of mixed hyperlipemia. Relative rates against artificial substrates and human chylomicrons.

Authors:  D E Wilson; P H Schreibman; R A Arky
Journal:  Diabetes       Date:  1969-08       Impact factor: 9.461

10.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.

Authors:  T G Redgrave
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  3 in total

1.  Primary hyperlipoproteinemia type I.

Authors:  H S Rane; R Garu; K R Lahari; A J Desai
Journal:  Indian J Pediatr       Date:  1984 Mar-Apr       Impact factor: 1.967

2.  Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.

Authors:  R M Krauss; R I Levy; D S Fredrickson
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

3.  Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.

Authors:  T Gotoda; N Yamada; M Kawamura; K Kozaki; N Mori; S Ishibashi; H Shimano; F Takaku; Y Yazaki; Y Furuichi; T Murase
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.